Value
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 5.7 |
| P/S | 8.6 |
| EV/EBITDA | 3.8 |
| Fwd P/E | 6.0 |
| PEG | 1.0 |
| Analyst target | 3.0 |
- ▸Forward P/E: 21.4x
- ▸PEG: 9.30
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
| Pillar | Expectation | Trend |
|---|---|---|
The business achieves a perfect Piotroski score of 9 out of 9, with strong gross and operating margins and healthy free cash flow conversion, placing it among the higher-quality franchises in the consumer defensive space and providing a durable foundation even during periods of slower growth. Quality breakdown | Quality score remains above 7.0 for the next 4 quarters, with gross and operating margins holding at or above current levels. | →Stable |
| CounterHigh Piotroski scores can reflect past-period profitability rather than forward earnings power; if revenue softens — particularly given a low growth score — margin compression could erode quality metrics faster than the score currently signals. | ||
With 68% of operations based in Europe, the business carries substantial geographic concentration risk; currency movements, regulatory changes, or regional demand softness could disproportionately impact revenue and margins without effective diversification to offset it. Bear case | European revenue contribution falls below 55% of total revenue for 2 consecutive quarters, reflecting meaningful geographic diversification into other markets. | →Stable |
| CounterA dominant European base in the fragrance and prestige beauty industry may reflect strategic positioning in the highest-margin global market rather than a structural vulnerability; European consumer demand for premium fragrances has historically shown resilience across economic cycles. | ||
Three consecutive positive earnings surprises in the most recent three quarters — with beats averaging roughly 11% above estimates and a full-year average positive surprise of about 6.4% — indicate the business is consistently delivering ahead of expectations, a pattern that typically supports multiple expansion over time. Earnings | EPS surprise remains positive for at least 3 of the next 4 quarters, sustaining the beat cadence that the most recent track record has established. | →Stable |
| CounterThree beats in a row can reflect a period of conservatively set guidance rather than accelerating operational performance; if external demand conditions in the fragrance market soften, the guidance discipline that produced the beats may not be sustainable. | ||
With the stock just below the short-term resistance target and only about 1.7% of headroom remaining, the reward-to-risk ratio has compressed to 0.25, meaning the available upside is a fraction of the potential downside; the setup does not justify adding to or initiating a position at these levels. Price targets | The reward-to-risk ratio improves above 1.5 as the stock retreats more than 10% from current levels, opening meaningful distance to the resistance target and restoring a favorable entry geometry. | →Stable |
| CounterResistance levels are not fundamental ceilings; if the analyst community raises price targets on the back of continued earnings beats, the take-profit level itself could migrate higher, improving the risk/reward structure without requiring a price pullback. | ||
A critical event disclosed in a recent regulatory filing has triggered a hard gate failure in the quality assessment; until the nature and financial consequences of the disclosure are fully understood, this represents an unquantified downside risk layered on top of an already unfavorable risk/reward setup. Engine gate (failed) | The matter underlying the critical regulatory filing is resolved with no restatement of prior financials and no adverse revenue impact exceeding 5% of quarterly sales, and no additional critical filings are made over the next 4 quarters. | →Stable |
| CounterNot every critical regulatory filing results in material financial consequences; if the disclosed event is administrative or involves a personnel or auditor change that the company has already managed, the market may absorb it without a meaningful re-rating. | ||
CounterHigh Piotroski scores can reflect past-period profitability rather than forward earnings power; if revenue softens — particularly given a low growth score — margin compression could erode quality metrics faster than the score currently signals.
CounterA dominant European base in the fragrance and prestige beauty industry may reflect strategic positioning in the highest-margin global market rather than a structural vulnerability; European consumer demand for premium fragrances has historically shown resilience across economic cycles.
CounterThree beats in a row can reflect a period of conservatively set guidance rather than accelerating operational performance; if external demand conditions in the fragrance market soften, the guidance discipline that produced the beats may not be sustainable.
CounterResistance levels are not fundamental ceilings; if the analyst community raises price targets on the back of continued earnings beats, the take-profit level itself could migrate higher, improving the risk/reward structure without requiring a price pullback.
CounterNot every critical regulatory filing results in material financial consequences; if the disclosed event is administrative or involves a personnel or auditor change that the company has already managed, the market may absorb it without a meaningful re-rating.
A high-quality franchise scoring 9 out of 9 on the Piotroski financial health scale and three consecutive earnings beats underpin a structurally sound business, but with the stock just below short-term resistance, the remaining upside of about 1.7% is dwarfed by the downside, and a critical regulatory filing event adds a near-term overhang that the setup does not compensate adequately.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Component | Sub-score |
|---|---|
| P/E | 5.7 |
| P/S | 8.6 |
| EV/EBITDA | 3.8 |
| Fwd P/E | 6.0 |
| PEG | 1.0 |
| Analyst target | 3.0 |
| Component | Sub-score |
|---|---|
| ROE | 6.6 |
| ROA | 7.5 |
| Gross margin | 7.8 |
| Op margin | 8.6 |
| Net margin | 5.7 |
| Current ratio | 9.7 |
| FCF quality | 6.1 |
| Moat | 7.2 |
| Piotroski F | 10.0 |
| Component | Sub-score |
|---|---|
| Rev growth | 2.9 |
| EPS growth | 2.5 |
| Component | Sub-score |
|---|---|
| RSI | 4.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 7.5 |
| Volume | 2.4 |
| Component | Sub-score |
|---|---|
| Analyst rating | 7.6 |
| Price target | 3.6 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
| Component | Sub-score |
|---|---|
| value rank | 3.7 |
| quality rank | 7.4 |
| growth rank | 5.3 |
| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.1 |
| 52w position | 7.7 |
| Component | Sub-score |
|---|---|
| short interest | 5.6 |
| days to cover | 3.5 |
| volatility | 4.0 |
| put call | 8.9 |
| implied vol | 5.8 |
| beta | 6.4 |
| debt equity | 9.3 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 5.7 |
| dividend safety | 6.0 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLnone
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $3.8B<$5B
The F-path SELL output reflects an overall score of 5.2 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 7.7) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.4=NEGATIVE, 8K_CRITICAL:4.01) reinforce the read. Current asymmetry R:R is -1.43 — supplementary context, not the trigger for this path.
The strongest dimensions are Quality at 7.7, Momentum at 6.8, and Risk (lower is worse) at 6.2; the weakest are Technical at 2.6, Growth at 2.7, and Value at 4.4. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of -1.43 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifQuality score falls below 6.0 for 2 consecutive quarters.
Trip ifEPS surprise falls below -5% for 2 consecutive quarters.
Trip ifEuropean revenue contribution falls below 55% of total revenue for 2 consecutive quarters.
Trip ifReward-to-risk ratio rises above 1.5, supported by a price retreat of more than 10% from current levels.
Trip ifThe regulatory filing matter is fully resolved with no adverse financial impact exceeding 5% of quarterly revenue, and no additional critical filings are disclosed in the subsequent 4 quarters.